Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial" l

Marco Marietta, Armando Tripodi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)239-240
Number of pages2
JournalBlood Transfusion
Volume18
Issue number3
DOIs
Publication statusPublished - May 2020

ASJC Scopus subject areas

  • Immunology and Allergy
  • Hematology

Cite this